MMMartin Moser

Martin Moser

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Martin Moser has a total of 43 co-authors. Here are the top co-authors by number of shared publications:

  • Christoph Bode

    7 shared publications
  • Jennifer Susanne Esser

    Department of Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Hugstetter Strasse 55, 79106, Freiburg im Breisgau, Germany

    4 shared publications
  • Qian Zhou

    Department of Cardiology and Angiology I, Heart Center, Medical Faculty, University of Freiburg, Freiburg, Germany

    3 shared publications
  • Cam Patterson

    New York Presbyterian Hospital, Weill Cornell Medical Center, 525 East 68th Street, Payson 118, New York, NY, USA

    2 shared publications
  • Christoph B. Olivier

    Department of Cardiology and Angiology, University Heart Center Freiburg – Bad Krozingen, Faculty of Medicine, University of Freiburg, Freiburg, Germany

    2 shared publications
  • Christoph Bode

    University Heart Center, Department of Cardiology and Angiology I, University of Freiburg and Faculty of Medicine, 55 Hugstetter St, 79106, Freiburg, Germany

    2 shared publications

Latest Publications

  • Antithrombotisches Management nach akutem oder chronischem Koronarsyndrom

    by Martin Moser, Dirk Westermann

    Zusammenfassung: Nach akutem oder chronischem Koronarsyndrom mit Koronarintervention ist eine antithrombotische Therapie mit dualer Plättchenhemmung erforderlich. Die Intensität und Dauer der Therapie unterscheiden sich je nach Indikation. Für besondere Situationen mit erhöhtem ischämischem Risiko oder erhöhtem Blutungsrisiko liegen Studiendaten vor, auf deren Basis fundierte Entscheidungen zur Intensivierung oder auch zur Deeskalation der Standardtherapie getroffen werden können, um das Nutzen-Risiko-Verhältnis zu optimieren.

  • SOPAntithrombotische Therapie bei Patienten mit Koronarintervention und Indikation zur Antikoagulation

    by Martin Moser, Christoph Bode

    Die antithrombotische Therapie in der Kardiologie hat in den letzten Jahren eine bemerkenswerte Entwicklung genommen. Neue Medikamente wurden entwickelt und bekannte und neue klinische Indikationen sind in großen Studien sorgfältig überprüft worden. Hier wird die Entscheidungsfindung zur kombinierten, antithrombotischen Therapie bei Patienten mit einer Indikation zur Gerinnungshemmung und gleichzeitiger Koronarintervention dargestellt. Publication Date: 14 December 2021 (online) © 2021. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany

  • Open Access

    Platelet Bone Morphogenetic Protein-4 Mediates Vascular Inflammation and Neointima Formation after Arterial Injury

    by Marietta Jank, Nikolaus von Niessen, Christoph B. Olivier, Hannah Schmitt, Nathaly Anto-Michel, Ingo Hilgendorf, Christoph Bode, Martin Moser, Jennifer S. Esser, Qian Zhou

    The purpose of this study is to investigate the role of platelet bone morphogenetic proteins (BMP)-4 during vascular inflammation and remodeling in a mouse model of carotid wire injury. Transgenic mice with a platelet-specific deletion of BMP-4 (BMP4Plt−/−) were generated. Intravital microscopy was performed to evaluate leukocyte adhesion to the vessel wall. Expression of adhesion molecules and chemokines were analyzed. Platelet-leukocyte aggregates (PLAs) were evaluated using flow cytometry. For carotid wire injury, BMP4Plt−/− mice were further crossed with LDLr−/− mice (BMP4Plt−/−/LDLr−/−) and fed with a high cholesterol diet for 2-weeks. Carotid wire injury was performed, and re-endothelialization and neointimal formation were evaluated. In comparison to the control mice, stimulation with TNFα resulted in fewer rolling and adherent leukocytes to the vessel wall in the BMP4Plt−/− mice. mRNA and protein expression of P-selectin and adhesion molecules were reduced in the aorta of the BMP4Plt−/− mice. In platelets from the BMP4Plt−/− mice, the expression of P-selectin was reduced, and fewer PLA formations were measured than in the control mice. Loss of platelet BMP-4 further prevented neointima formation after carotid wire injury. Endothelial regeneration after injury was decelerated in the BMP4Plt−/− mice, and confirmed in-vitro, where the deletion of platelet BMP-4 inhibited endothelial cell proliferation and migration. We demonstrate for the first time that platelet BMP-4 is involved during vascular inflammation and remodeling. This is partially mediated by the inhibition of platelet activation, reduced expression of adhesion molecules and inflammatory responses. Our findings identify platelet BMP-4 as a mediator of vascular inflammation in early atherosclerosis and restenosis.


  • Antithrombotische Therapie bei Patienten mit Koronarstent und Vorhofflimmern

    by Martin Moser, Christoph Bode

    Die Auswahl eines geeigneten antithrombotischen Regimes für Patienten mit Vorhofflimmern, die sich einer perkutanen Koronarintervention unterziehen müssen, ist in dieser kombinierten Indikation schwierig und mit potenziellen Problemen in Hinblick auf das thrombembolische und Blutungsrisiko behaftet. Dieser Beitrag gibt einen Überblick über die aktuellen Therapieempfehlungen für diese kritische Patientengruppe. Publication Date: 17 March 2021 (online) © 2021. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany

  • Open Access

    Extracellular HtrA2 Induces Apoptosis in Human Umbilical Vein Endothelial Cells

    by Gurpinder Kaur, Daniela Stallmann, Nancy Schanze, Rosmarie Laumann, Lukas Andreas Heger, Johannes Steinfurt, Peter Stachon, Karlheinz Peter, Christoph Bode, Martin Moser, et al.

    The serine protease high-temperature-required protein A2 (HtrA2) has been identified as a key intracellular molecule promoting apoptosis in cells during ischemia reperfusion (IR) injury. IR injury in ST-segment elevation myocardial infarction (STEMI) contributes to overall myocardial damage. HtrA2 has further been shown to be significantly increased in the serum of patients with STEMI. In the present pilot study, we use human umbilical vein endothelial cells (HUVECs) to investigate whether extracellular HtrA2 induces apoptosis using Annexin V staining. Furthermore, we examine whether HtrA2 is released extracellularly after staurosporine-induced apoptosis using ELISA. We find that HtrA2 is released upon induction of apoptosis by staurosporine into the cell culture medium. Furthermore, treatment of HUVECs with extracellular HtrA2-induces apoptosis, while the addition of anti-HtrA2 antibodies reduces both HtrA2- and staurosporine-induced endothelial cell apoptosis. In conclusion, we show here that extracellular HtrA2 induces apoptosis in human endothelial cells, although the exact molecular mechanisms have to be investigated in future.


  • Kombinierte antithrombotische Therapiestrategien in der Kardiologie

    by Martin Moser

    Nach koronarer Stentimplantation ist die duale Plättchentherapie genauso üblich wie andererseits die Antikoagulation bei Vorhofflimmern. Weil die neuen oralen Antikoagulanzien die Vitamin-K-Antagonisten zunehmend ablösen, rückt aber eine kombinierte antithrombotische Therapie bei Indikationen in den Fokus, die bisher der Plättchentherapie vorbehalten waren.

  • NOAKs zur Schlaganfallprävention bei Vorhofflimmern

    by Johannes Rotta Detto Loria, Christoph Bode, Martin Moser

    Vorhofflimmern kann Ursache für intrakardiale Thromben und thromboembolische Ereignisse sein, was es zu einer potenziell lebensbedrohlichen Erkrankung macht. Abhängig vom individuellen Schlaganfallrisiko muss deshalb effektiv antikoaguliert werden. Aufgrund des guten Sicherheitsprofils und der einfachen Handhabung sind NOAKs bei der Neueinstellung betroffener Patienten die erste Wahl. Auswahl und korrekte Dosierung des Präparats sind für den Therapieerfolg entscheidend.

  • The neuronal transcription factor NPAS4 is a strong inducer of sprouting angiogenesis and tip cell formation

    by Jennifer Susanne Esser, Anne Charlet, Mei Schmidt, Sophia Heck, Anita Allen, Achim Lother, Daniel Epting, Cam Patterson, Christoph Bode, Martin Moser

    Regarding branching morphogenesis, neurogenesis and angiogenesis share common principle mechanisms and make use of the same molecules. Therefore, the investigation of neuronal molecules involved in vascular morphogenesis provides new possibilities for pro-angiogenic approaches in cardiovascular diseases. In this study, we investigated the role of the neuronal transcription factor NPAS4 in angiogenesis. Here, we demonstrate that the neuronal transcription factor NPAS4 is expressed in endothelial cells of different origin using reverse transcription PCR and western blot analysis. To investigate how NPAS4 affects endothelial cell function, NPAS4 was overexpressed by plasmid transfection or depleted from human umbilical vein endothelial cells (HUVECs) by specific siRNAs. In vitro HUVEC sprouting assays showed that sprouting and branching of endothelial cells was enhanced by NPAS4 overexpression. Consistently, silencing of NPAS4 resulted in reduced HUVEC sprouting and branching. Mechanistically, we identified as target gene vascular endothelial adhesion molecule VE-cadherin to be involved in the pro-angiogenic function of NPAS4. In endothelial cell mosaic spheroid sprouting assays, NPAS4 was involved in tip cell formation. In vivo experiments in mouse and zebrafish confirmed our in vitro findings. NPAS4-deficient mice displayed reduced ingrowth of endothelial cells in the Matrigel plug assay. Consistent with a regulatory role of NPAS4 in endothelial cell function silencing of NPAS4 in zebrafish by specific morpholinos resulted in perturbed intersegmental vessels growth. NPAS4 is expressed in endothelial cells, regulates VE-cadherin expression and regulates sprouting angiogenesis.


  • MnTBAP increases BMPR-II expression in endothelial cells and attenuates vascular inflammation

    by Qian Zhou, Michaela Einert, Hannah Schmitt, Zhengguan Wang, Franziska Pankratz, Christoph B. Olivier, Christoph Bode, James K. Liao, Martin Moser